Variant report
Variant | nsv947540 |
---|---|
Chromosome Location | chr1:103643208-103649306 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs568953420 | chr1:103643233-103643234 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs192420360 | chr1:103643248-103643249 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs564353131 | chr1:103643333-103643334 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs554796284 | chr1:103643377-103643378 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs544093112 | chr1:103643380-103643381 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs534003596 | chr1:103643411-103643412 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs145375675 | chr1:103643432-103643433 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs72687257 | chr1:103643500-103643501 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs185558002 | chr1:103643505-103643506 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs190434111 | chr1:103643522-103643523 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs577754557 | chr1:103643530-103643531 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs142535084 | chr1:103643545-103643546 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs7533628 | chr1:103643575-103643576 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs562962811 | chr1:103643594-103643595 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs7536068 | chr1:103643595-103643596 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs542391105 | chr1:103643598-103643599 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs61815040 | chr1:103643624-103643625 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs541969508 | chr1:103643625-103643626 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs67444477 | chr1:103643626-103643627 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs61166491 | chr1:103643628-103643629 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs57806402 | chr1:103643630-103643631 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs141268529 | chr1:103643637-103643638 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs201671607 | chr1:103643638-103643639 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs546336068 | chr1:103643661-103643662 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs565138497 | chr1:103643734-103643735 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs532559058 | chr1:103643748-103643749 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs550898151 | chr1:103643751-103643752 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs146905455 | chr1:103643835-103643836 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs557126804 | chr1:103643845-103643846 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs139308534 | chr1:103643848-103643849 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs370207453 | chr1:103643851-103643852 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs34615806 | chr1:103643852-103643853 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs548582485 | chr1:103643891-103643892 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs143642097 | chr1:103643894-103643895 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs374320657 | chr1:103643904-103643905 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs200298055 | chr1:103643964-103643965 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs11810850 | chr1:103643990-103643991 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs181605862 | chr1:103643998-103643999 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs60582212 | chr1:103644051-103644052 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs186074263 | chr1:103644136-103644137 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs557318427 | chr1:103644143-103644144 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs112065691 | chr1:103644156-103644157 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs542523312 | chr1:103644191-103644192 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs189220025 | chr1:103644307-103644308 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs141912364 | chr1:103644324-103644325 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs540365126 | chr1:103644356-103644357 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs570823721 | chr1:103644360-103644361 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs532596044 | chr1:103644364-103644365 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs544424692 | chr1:103644368-103644369 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs112866165 | chr1:103644381-103644382 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 22429812 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Autism | 17483303 | CNVD |
Intestinal disease | 21956041 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Schizophrenia | 17879154 | CNVD |
Mental retardation | 17124404 | CNVD |
Intestinal disease | 17828263 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Immune disease | 21076436 | CNVD |
Immune disease | 21042300 | CNVD |
Lung cancer | 17086460 | CNVD |
Gastric cancer | 16891809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:103637200-103646000 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
2 | chr1:103641200-103644000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr1:103643800-103644400 | Enhancers | A549 | lung |
4 | chr1:103644000-103646200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
5 | chr1:103644400-103646400 | Weak transcription | A549 | lung |
6 | chr1:103646000-103646600 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
7 | chr1:103646000-103647200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
8 | chr1:103646000-103647200 | Enhancers | HSMM | muscle |
9 | chr1:103646000-103647200 | Enhancers | NH-A | brain |
10 | chr1:103646000-103647400 | Enhancers | Muscle Satellite Cultured Cells | -- |
11 | chr1:103646000-103647400 | Enhancers | Fetal Heart | heart |
12 | chr1:103646200-103646600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
13 | chr1:103646200-103646600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
14 | chr1:103646200-103646600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
15 | chr1:103646200-103646600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
16 | chr1:103646200-103646600 | Enhancers | Cortex derived primary cultured neurospheres | brain |
17 | chr1:103646200-103646600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
18 | chr1:103646400-103646800 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
19 | chr1:103646400-103646800 | Active TSS | A549 | lung |
20 | chr1:103646800-103647200 | Enhancers | A549 | lung |
21 | chr1:103647200-103659400 | Weak transcription | HSMM | muscle |
22 | chr1:103647400-103647600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |